Tag Archives: NIH

NIH, Patients and Industry Ramp Up to AMP-lify Innovation

Kay Holcomb

Speakers at Wednesday’s BIO 2014 Super Session – AMP-lifying Innovation: NIH, Patient Organizations & Leading Biopharma Firms Mobilize to Tackle Tough Diseases – discussed the new Accelerating Medicines Partnership (AMP) program, which is aimed at transforming the current model for developing new treatments by jointly identifying and validating promising biological targets of disease. AMP is a new venture among the NIH, several non-profit organizations and 10 biopharmaceutical companies focused on Alzheimer’s disease; type 2 diabetes Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,

Expand Investment in Basic Research Needed to Advance Medical Progress

Michael Coburn

In 2007, the Napier and Lane families struggled to find answers to their daughters’ developmental problems, which included impaired communication and socialization skills. Both of the girls had a disorder so rare that it subsequently became identified only by the name of the small fragment of chromosome 16 that was missing, namely “16p11.2 deletion syndrome.” Dan Pinkel and Joe Gray, researchers at the University of California, San Francisco developed microarray comparative genomic hybridization, a technology Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , ,

BIO Testifies at 21st Century Cures Hearing on PCAST

TheHill

Today, BIO’s Executive Vice President of Health Sara Radcliffe presented testimony to the U.S. House of Representatives Energy and Commerce Subcommittee on Health Hearing. The Hearing focused on the President’s Council of Advisors on Science and Technology (PCAST) Report on Drug Innovation and key issues related to the 21st Century Cures initiative to examine what steps the Committee can take to accelerate the pace of cures in America. Below is a summary: The Challenge of Read More >

Health, Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

Driving Innovation through Federal Investments

Biopharmaceuticals and Accountable Care Organizations: Balancing Cost and Quality

Today, BIO submitted testimony to the Senate Committee on Appropriations on the importance of driving innovation through federal investments. Below are highlights of our written testimony. NIH:  A Driver of the Innovation Pipeline We must continue to invest in scientific discovery.  NIH-supported biomedical research builds the foundation of scientific and clinical knowledge that is widely communicated and used to improve the treatment of patients and underpin the development of new diagnostics, treatments, vaccines, and cures. Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

NIH & NSF SBIR/STTR Programs

InnovationZone_Logo_SBIR Companies_VERT_lockup

Leveraging Small Business to Bring Life-Saving Innovations to the Market. A key part of the National Institutes of Health (NIH) and the National Science Foundation (NSF)’s mission is the translation of basic discoveries into innovative technologies that improve human health, and the NIH and NSF Small Business Innovation Research and Small Business Technology Transfer (SBIR/STTR) programs strive to do just that. NIH is the premier biomedical research funding organization in the world, and has a 2014 SBIR/STTR Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , ,